Navigation Links
Diabetes Care Devices in Emerging Countries (China, India, Brazil) to 2017 - Greater Awareness is Increasing Demand for Self-Monitoring of Blood Glucose (SMBG) in the Home Care Segment
Date:6/28/2012

NEW YORK, June 28, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Diabetes Care Devices in Emerging Countries (China, India, Brazil) to 2017 - Greater Awareness is Increasing Demand for Self-Monitoring of Blood Glucose (SMBG) in the Home Care Segment

http://www.reportlinker.com/p0832798/Diabetes-Care-Devices-in-Emerging-Countries-China-India-Brazil-to-2017---Greater-Awareness-is-Increasing-Demand-for-Self-Monitoring-of-Blood-Glucose-SMBG-in-the-Home-Care-Segment.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

Diabetes Care Devices in Emerging Countries (China, India, Brazil) to 2017 - Greater Awareness is Increasing Demand for Self-Monitoring of Blood Glucose (SMBG) in the Home Care Segment

Summary

GBI Research's report, "Diabetes Care Devices in Emerging Countries (China, India, Brazil) to 2017 - Greater Awareness is Increasing Demand for Self-Monitoring of Blood Glucose (SMBG) in the Home Care Segment" provides key data, information and analysis on the emerging countries diabetes care devices market. The report provides market landscape, competitive landscape and market trends information on two diabetes care devices market categories – Insulin Delivery (Insulin Pens, Traditional Insulin Pump Accessories, Insulin Pumps, Insulin Syringes) and Glucose Monitoring (Blood Glucose Test Strips, Blood Glucose Meters, Lancets). The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape with key marketed products and a detailed analysis of the pipeline products in each category. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

  • Key geographies covered include the China, India and Brazil.
  • Market size data for two diabetes care devices market categories – Insulin Delivery (Insulin Pens, Traditional Insulin Pump Accessories, Insulin Pumps, Insulin Syringes) and Glucose Monitoring (Blood Glucose Test Strips, Blood Glucose Meters, Lancets).
  • Annualized market revenues data, forecast forward for seven years to 2017. Company shares data for 2010.
  • Qualitative analysis of key market trends for diabetes care devices imaging equipment in emerging countries market.
  • Qualitative analysis of market drivers and restraints by each category within the diabetes care devices market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading technologies.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the diabetes care devices market in emerging countries.
  • Design and develop your product development, marketing and sales strategies in emerging countries.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline in emerging countries.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • What's the next big thing in the diabetes care devices market landscape – Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the diabetes care devices market in emerging countries and the factors shaping it.

1 Table of Contents1 Table of Contents 41.1 List of Tables 71.2 List of Figures 82 Introduction 92.1 GBI Research Guidance 103 Disease Overview - Diabetes 113.1 Type 1 Diabetes 113.1.1 Introduction 113.1.2 Etiology, Disease Symptoms and Risk Factors 113.2 Type 2 Diabetes 113.2.1 Introduction 113.2.2 Etiology, Disease Symptoms and Risk Factors 113.2.3 Epidemiology 124 Diabetes Care Devices, Emerging Countries - Market Characterization 134.1 Diabetes Care Devices Market, Emerging Countries (China, India, Brazil), Revenue ($m), 2003–2010 134.2 Diabetes Care Devices Market, Emerging Countries (China, India, Brazil), Revenue ($m), 2010–2017 144.3 Diabetes Care Devices Market, Emerging Countries (China, India, Brazil), Company Share (%), 2010 154.3.1 Diabetes Care Devices Market, China, Company Share (%), 2010 174.3.2 Diabetes Care Devices Market, India, Company Share (%), 2010 184.3.3 Diabetes Care Devices Market, Brazil, Company Share (%), 2010 204.4 Diabetes Care Devices, Emerging Countries: Market Dynamics 214.4.1 Market Drivers 214.4.2 Market Restraints 275 Diabetes Care Devices Market, Emerging Countries - Category Analysis 295.1 Insulin Delivery Devices - Overview 295.1.1 Insulin Pens 295.1.2 Traditional Insulin Pump Accessories 295.1.3 Traditional Insulin Pumps 295.1.4 Insulin Syringes 295.2 Insulin Delivery Devices Market, Emerging Countries, Revenue ($m), 2003–2017 305.2.1 Insulin Delivery Devices Market, China, Revenue ($m), 2003–2010 305.2.2 Insulin Delivery Devices Market, China, Revenue ($m), 2010–2017 315.2.3 Insulin Delivery Devices Market, India, Revenue ($m), 2003–2010 325.2.4 Insulin Delivery Devices Market, India, Revenue ($m), 2010–2017 335.2.5 Insulin Delivery Devices Market, Brazil, Revenue ($m), 2003–2010 345.2.6 Insulin Delivery Devices Market, Brazil, Revenue ($m), 2010–2017 355.3 Insulin Delivery Devices Market, Emerging Countries, Company Share (%), 2010 365.3.1 Insulin Delivery Devices Market, China, Company Share (%), 2010 365.3.2 Insulin Delivery Devices Market, India, Company Share (%), 2010 375.3.3 Insulin Delivery Devices Market, Brazil, Company Share (%), 2010 385.4 Insulin Delivery Devices, Emerging Countries, Market Dynamics 395.4.1 Market Drivers 395.4.2 Market Restraint 405.5 Glucose Monitoring Devices: Overview 425.5.1 Blood Glucose Meters 425.5.2 Blood Glucose Test Strips 425.5.3 Lancets 425.6 Glucose Monitoring Devices, Emerging Countries, Revenue ($m), 2003–2017 435.6.1 Glucose Monitoring Devices Market, China, Revenue ($m), 2003–2010 435.6.2 Glucose Monitoring Devices Market, China, Revenue ($m), 2010–2017 445.6.3 Glucose Monitoring Devices Market, India, Revenue ($m), 2003–2010 455.6.4 Glucose Monitoring Devices Market, India, Revenue ($m), 2010–2017 465.6.5 Glucose Monitoring Devices Market, Brazil, Revenue ($m), 2003–2010 475.6.6 Glucose Monitoring Devices Market, Brazil, Revenue ($m), 2010–2017 485.7 Glucose Monitoring Devices Market, Emerging Countries, Company Share (%), 2010 495.7.1 Glucose Monitoring Devices Market, China, Company Share (%), 2010 495.7.2 Glucose Monitoring Devices Market, India, Company Share (%), 2010 505.7.3 Glucose Monitoring Devices Market, Brazil, Company Share (%), 2010 515.8 Glucose Monitoring Devices, Emerging Countries, Market Dynamics 525.8.1 Market Drivers 525.8.2 Market Restraints 536 Diabetes Care Devices Market, Emerging Countries (China, India, Brazil) - Competitive Assessment 546.1 F. Hoffmann-La Roche Ltd. 576.1.1 Overview 576.1.2 Marketed Products, Diabetes Care Devices 576.2 LifeScan, Inc. (Johnson & Johnson) 576.2.1 Overview 576.2.2 Marketed Products, Diabetes Care Devices 576.3 Novo Nordisk A/S 586.3.1 Overview 586.3.2 Marketed Products, Diabetes Care Devices 586.4 Medtronic, Inc. 586.4.1 Overview 586.4.2 Marketed Products, Diabetes Care Devices 596.5 Abbott Laboratories 596.5.1 Overview 596.5.2 Marketed Products, Diabetes Care Devices 596.6 Bayer HealthCare AG 596.6.1 Overview 596.6.2 Marketed Products, Diabetes Care Devices 606.7 Becton, Dickinson and Company 606.7.1 Overview 606.7.2 Marketed Products, Diabetes Care Devices 606.8 Sanofi 606.8.1 Overview 606.8.2 Marketed Products, Diabetes Care Devices 616.9 Eli Lilly and Company 616.9.1 Overview 616.9.2 Marketed Products, Diabetes Care Devices 616.10 Hindustan Syringes & Medical Devices Ltd. 626.10.1 Overview 626.10.2 Marketed Products, Diabetes Care Devices 627 Diabetes Care Devices, Emerging Countries (China, India, Brazil) - Pipeline Assessment 637.1 Diabetes Care Devices, Emerging Countries (China, India, Brazil), Pipeline Products Summary 637.1.1 MIT-P-I 637.1.2 Mylife OmniPod 647.1.3 V Pump 647.1.4 Patch Insulin Pump 657.1.5 Spring Hybrid Patch Pump 657.1.6 ClikSTAR 657.1.7 BGStar 668 Diabetes Care Devices Market, Emerging Countries (China, India, Brazil) - Deals Analysis 678.1 Diabetes Care Devices Market, Mergers and Acquisitions, Emerging Countries (China, India, Brazil), 2007–2011 678.2 Key Deals, Diabetes Care Devices Market, 2007–2011 678.2.1 MicroPort Medical Acquires Beijing Pangerui Medical 679 Appendix 689.1 Definitions 689.1.1 Diabetes Care Devices 689.1.2 Glucose Monitoring 689.1.3 Blood Glucose Meters 689.1.4 Blood Glucose Test Strips 689.1.5 Lancets 689.1.6 Insulin Delivery 689.1.7 Insulin Pens 689.1.8 Insulin Pumps 699.1.9 Insulin Syringes 699.1.10 Traditional Insulin Pump Accessories 699.2 Acronyms 699.3 Sources 709.4 Research Methodology 709.5 Secondary Research 719.6 Primary Research 719.7 Models 719.8 Forecasts 729.9 Expert Panels 729.10 Contact Us 729.11 Disclaimer 72

1.1 List of Tables

Table 1: Diabetes Prevalence (%), Emerging Countries (China, India, Brazil), 2011 12Table 2: Diabetes Care Devices, Emerging Countries (China, India, Brazil), Revenue ($m), 2003–2010 13Table 3: Diabetes Care Devices, Emerging Countries (China, India, Brazil), Revenue ($m), 2010–2017 14Table 4: Diabetes Care Devices Market, Emerging Countries (China, India, Brazil), Company Revenue ($m), 2010 15Table 5: Diabetes Care Devices Market, China, Company Revenue ($m), 2010 17Table 6: Diabetes Care Devices Market, India, Company Revenue ($m), 2010 18Table 7: Diabetes Care Devices Market, Brazil, Company Revenue ($m), 2010 20Table 8: Diabetes Prevalence (%),Emerging Countries (China, India, Brazil), 2011 22Table 9: List of Diabetes Awareness and Prevention Programs in Emerging Countries (China, India and Brazil), 2011 24Table 10: Insulin Delivery Devices Market, China, Revenue ($m), 2003–2010 30Table 11: Insulin Delivery Devices Market, China, Revenue ($m), 2010–2017 31Table 12: Insulin Delivery Devices Market, India, Revenue ($m), 2003–2010 32Table 13: Insulin Delivery Devices Market, India, Revenue ($m), 2010–2017 33Table 14: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2003–2010 34Table 15: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2010–2017 35Table 16: Insulin Delivery Devices Market, China, Company Revenue ($m), 2010 36Table 17: Insulin Delivery Devices Market, India, Company Revenue ($m), 2010 37Table 18: Insulin Delivery Devices Market, Brazil, Company Revenue ($m), 2010 38Table 19: Insulin Pens, Average Selling Price ($), 2010 39Table 20: Incidence Rates of Type 1 Diabetes in Children, Emerging Countries, 2010 39Table 21: Insulin Pumps, Average Selling Price, 2010 40Table 22: Studies Suggesting Higher Risk of Ketoacidosis from Insulin Pump Use, 2004 & 2009 41Table 23: Glucose Monitoring Devices Market, China, Revenue ($m), 2003–2010 43Table 24: Glucose Monitoring Devices Market, China, Revenue ($m), 2010–2017 44Table 25: Glucose Monitoring Devices Market, India, Revenue ($m), 2003–2010 45Table 26: Glucose Monitoring Devices Market, India, Revenue ($m), 2010–2017 46Table 27: Glucose Monitoring Devices Market, Brazil, Revenue ($m), 2003–2010 47Table 28: Glucose Monitoring Devices Market, Brazil, Revenue ($m), 2010–2017 48Table 29: Glucose Monitoring Devices Market, China, Company Revenue ($m), 2010 49Table 30: Glucose Monitoring Devices Market, India, Company Revenue ($m), 2010 50Table 31: Glucose Monitoring Devices Market, Brazil, Company Revenue ($m), 2010 51Table 32: Key Hospital Groups Planning Expansion in Tier II and Tier III Regions in India, 2010 52Table 33: F Hoffman-La Roche, Key Marketed Products, Emerging Countries 57Table 34: LifeScan (Johnson & Johnson), Key Marketed Products, Emerging Countries 57Table 35: Novo Nordisk, Key Marketed Products, Emerging Countries 58Table 36: Medtronic, Key Marketed Products, Emerging Countries 59Table 37: Abbott Laboratories, Key Marketed Products, Emerging Countries 59Table 38: Bayer Healthcare, Key Marketed Products, Emerging Countries 60Table 39: Becton, Dickinson and Company, Key Marketed Products, Emerging Countries 60Table 40: Sanofi, Key Marketed Products, Emerging Countries 61Table 41: Eli Lilly and Company, Key Marketed Products, Emerging Countries 61Table 42: Hindustan Syringes & Medical Devices Ltd., Key Marketed Products, Emerging Countries 62Table 43: Diabetes Care Devices Market, Emerging Countries (China, India, Brazil), Pipeline Products Summary, 2011 63Table 44: MIT-P-I, Product Status, 2011 63Table 45: Mylife OmniPod, Product Status, 2011 64Table 46: V Pump, Product Status, 2011 64Table 47: Patch Insulin Pump, Product Status, 2011 65Table 48: Spring Hybrid Patch Pump, Product Status, 2011 65Table 49: ClikSTAR, Product Status, 2011 66Table 50: BGStar, Product Status, 2011 66Table 51: Diabetes Care Devices Market, Mergers and Acquisitions, Emerging Countries (China, India, Brazil), 2007–2011 67

1.2 List of Figures

Figure 1: Diabetes Care Devices, Market Segmentation 9Figure 2: Diabetes Prevalence (%), Emerging Countries (China, India, Brazil), 2011 12Figure 3: Diabetes Care Devices Market, Emerging Countries (China, India, Brazil), Revenue ($m), 2003–2010 13Figure 4: Diabetes Care Devices Market, Emerging Countries (China, India, Brazil), Revenue ($m), 2010–2017 14Figure 5: Diabetes Care Devices Market, Emerging Countries (China, India, Brazil), Company Share (%), 2010 15Figure 6: Diabetes Care Devices Market, China, Company Share (%), 2010 17Figure 7: Diabetes Care Devices Market, India, Company Share (%), 2010 18Figure 8: Diabetes Care Devices Market, Brazil, Company Share (%), 2010 20Figure 9: Diabetes Care Devices, Emerging Countries (China, India, Brazil), Market Dynamics 21Figure 10: Per Capita Expenditure on Healthcare, Emerging Countries (China, India, Brazil), 2005-2009 23Figure 11: Insulin Delivery Devices, Market Segmentation, 2011 29Figure 12: Insulin Delivery Devices Market, China, Revenue ($m), 2003– 2010 30Figure 13: Insulin Delivery Devices Market, China, Revenue ($m), 2010–2017 31Figure 14: Insulin Delivery Devices Market, India, Revenue ($m), 2003–2010 32Figure 15: Insulin Delivery Devices Market, India, Revenue ($m), 2010–2017 33Figure 16: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2003–2010 34Figure 17: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2010–2017 35Figure 18: Insulin Delivery Devices Market, China, Company Share (%), 2010 36Figure 19: Insulin Delivery Devices Market, India, Company Share (%), 2010 37Figure 20: Insulin Delivery Devices Market, Brazil, Company Share (%), 2010 38Figure 21: Reasons for Type 1 Diabetes in Children 40Figure 22: Glucose Monitoring Devices, Market Segmentation, 2011 42Figure 23: Glucose Monitoring Devices Market, China, Revenue ($m), 2003–2010 43Figure 24: Glucose Monitoring Devices Market, China, Revenue ($m), 2010–2017 44Figure 25: Glucose Monitoring Devices Market, India, Revenue ($m), 2003–2010 45Figure 26: Glucose Monitoring Devices Market, India, Revenue ($m), 2010–2017 46Figure 27: Glucose Monitoring Devices Market, Brazil, Revenue ($m), 2003–2010 47Figure 28: Glucose Monitoring Devices Market, Brazil, Revenue ($m), 2010–2017 48Figure 29: Glucose Monitoring Devices Market, China, Company Share (%), 2010 49Figure 30: Glucose Monitoring Devices Market, India, Company Share (%), 2010 50Figure 31: Glucose Monitoring Devices Market, Brazil, Company Share (%), 2010 51Figure 32: Diabetes Care Devices Market, China, Competitive Assessment, 2010 54Figure 33: Diabetes Care Devices Market, India, Competitive Assessment, 2010 55Figure 34: Diabetes Care Devices Market, Brazil, Competitive Assessment, 2010 56

Companies mentioned

F. Hoffmann-La Roche Ltd.
LifeScan, Inc. (Johnson & Johnson)
Novo Nordisk A/S
Medtronic, Inc.
Abbott Laboratories
Bayer HealthCare AG
Becton, Dickinson and Company
Sanofi
Eli Lilly and Company
Hindustan Syringes & Medical Devices Ltd.

To order this report: Drug Delivery Technology Industry: Diabetes Care Devices in Emerging Countries (China, India, Brazil) to 2017 - Greater Awareness is Increasing Demand for Self-Monitoring of Blood Glucose (SMBG) in the Home Care Segment 

More Market Research Report

Check our Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved


Related medicine technology :

1. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
2. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
3. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
4. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
5. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
6. Valeritas Inc. Selects dLifes New Diabetes Patient Engagement Solution For Valeritas V-go Disposable Insulin Delivery Device
7. Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe
8. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
9. JDRF and BD Collaborate to Develop More Accurate and Reliable Glucose Monitoring Devices for People with Type 1 Diabetes
10. Eleven Integrated Health Systems Form Largest Private-Sector Diabetes Registry in United States
11. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute lymphocytic Leukemia Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Leukemia Market and Competitive Landscape Highlights 2016, ... pipeline products, Acute Lymphocytic Leukemia epidemiology, Acute ...
(Date:5/3/2016)... to further expand product development, strengthen its disease modeling capabilities and increase market presence. Photo - ... ... ... ... Sino-German High-Tech Fund (SGHF) is an ...
(Date:5/3/2016)... watching a film or TV show in high definition, you may not be familiar with ...  is a renowned authorized reseller of the medical industry,s top brands as well as a ... ... ... Although initially introduced ...
Breaking Medicine Technology:
(Date:5/4/2016)... NY (PRWEB) , ... May 04, 2016 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – is set to return to the esteemed Quaker Ridge Golf Club in ...
(Date:5/4/2016)... York, NY (PRWEB) , ... May 04, 2016 ... ... leading private owners, developers and operators of commercial real estate proudly announced that ... 2015 Heart Health initiative. Team members portfolio-wide will continue Olshan Properties’ annual ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... Nurses (WOCN) Society™ and Canadian Association for Enterostomal Therapy (CAET) will be ... saving and planning tools to attendees and exhibitors for the 2016 WOCN Society ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... charity program created to assist the people of their local community. The agency ... organizations and community leaders. Their hope is to bring awareness to important local ...
(Date:5/4/2016)... ... May 04, 2016 , ... Slepkow Slepkow & ... one of the top website design companies to create a state of the ... to the law firm's main practice areas. These practice areas include: real estate, ...
Breaking Medicine News(10 mins):